TOP-N53

· Topadur Pharma AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TOP-N53, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis [Phase 2]